The gene therapy market is still in its infancy but poised for significant growth, with an approximate 25% increase in therapies in the pipeline as compared to 2018. However, the launch of a gene therapy is an event with limited case examples to follow and numerous unique considerations.
COVID-19 has brought an undeniable impact on the healthcare landscape. Are you prepared for the coming dynamic healthcare coverage shifts?
Precision's David Carr examines the 3 main drivers for change in the health care industry in the 2020's, and how health care players can and should adapt.
Read our interview with Olaf Koester on significant changes to the Patented Medicines Regulations set to go into effect July 1, 2020.
Gene therapies offer dramatic new hope to patients with a range of unmet medical needs—but at what price? From the payer perspective, not all benefits justify reimbursement. And that can spell trouble for manufacturers.
What began as patient call centers for select complex medicines has expanded to a full suite of support services, ranging from financial assistance to patient education.